What is BPC-157 and its mechanism of action?

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide (15 amino acid sequence) derived from a protective protein found in gastric juice. BPC-157's sequence is a partial segment of Body Protection Compound (BPC) with potent tissue-protective and regenerative properties. The peptide promotes healing through multiple synergistic mechanisms: (1) Angiogenesis stimulation - upregulating vascular endothelial growth factor (VEGF) expression and promoting new blood vessel formation to enhance nutrient/oxygen delivery to damaged tissues, (2) Growth factor modulation - influencing fibroblast growth factor (FGF) and platelet-derived growth factor (PDGF) signaling cascades, (3) Nitric oxide (NO) pathway regulation - modulating NO synthase activity affecting vasodilation and inflammation, (4) Collagen production enhancement - accelerating extracellular matrix synthesis for tissue repair, (5) Anti-inflammatory effects - downregulating pro-inflammatory cytokines, and (6) Cytoprotection - stabilizing cellular membranes and protecting against various stressors. This multi-faceted healing mechanism makes BPC-157 invaluable for tissue repair research, wound healing studies, angiogenesis investigations, and gastric protection research in laboratory models.

What research applications benefit from BPC-157 studies?

BPC-157 excels in wound healing and tissue repair research, angiogenesis and vascular growth factor pathway studies, gastric ulcer protection and gastrointestinal healing investigations, tendon and ligament injury repair research, muscle damage and regeneration studies, bone healing and fracture repair research, inflammatory pathway modulation analysis, neuroprotection and nerve injury repair studies, ischemia-reperfusion injury research, comparative healing peptide studies (BPC-157 vs TB-500 vs growth factors), cytoprotection mechanism research, and gastric pentadecapeptide pharmacology. Ideal for laboratories investigating tissue regeneration, angiogenic pathways, wound healing mechanisms, and peptide-based therapeutic strategies across multiple organ systems.

What purity and quality standards does your BPC-157 meet?

Our BPC-157 exceeds >98% purity verified by HPLC analysis. Each batch undergoes mass spectrometry molecular weight confirmation for the 15 amino acid pentadecapeptide structure, amino acid sequence verification, bioactivity testing using angiogenesis assays (endothelial tube formation, VEGF expression), wound healing scratch assays in cell culture, or fibroblast proliferation assays, endotoxin screening (<0.1 EU/mg), and comprehensive Certificate of Analysis documentation. The high purity ensures reproducible angiogenic and healing effects without degradation products, sequence truncations, or contaminants interfering with tissue repair research. Each batch is traceable with detailed analytical data supporting regulatory compliance for research applications.

Can BPC-157 be used in comparative tissue healing research?

Absolutely! BPC-157 serves as a reference angiogenic and healing peptide in comparative studies against TB-500 (Thymosin Beta-4), growth factors (VEGF, FGF, PDGF), other healing peptides, platelet-rich plasma (PRP) components, and stem cell therapies. Researchers use BPC-157 to investigate angiogenesis-dependent vs angiogenesis-independent healing mechanisms, compare peptide-based vs growth factor-based tissue repair strategies, study synergistic effects of combined healing interventions (BPC-157 + TB-500 blends), examine dose-response healing kinetics, and evaluate tissue-specific repair mechanisms (gastric vs tendon vs nerve vs muscle) in laboratory healing models. BPC-157's unique gastric origin and multi-pathway mechanism complement other healing research tools.

How should BPC-157 be stored and reconstituted?

Store lyophilized BPC-157 at -20°C in original sealed vials for 24+ months stability. The 15 amino acid sequence provides good chemical stability in lyophilized form with proper storage. Reconstitute with bacteriostatic water or sterile saline by adding solvent slowly down vial wall, then gently swirl (never shake) until completely dissolved at 0.5-2 mg/mL concentration. Refrigerate reconstituted solution at 2-8°C and use within 14 days. Avoid multiple freeze-thaw cycles to preserve angiogenic and tissue-protective bioactivity. For extended tissue healing studies requiring multiple dosing over weeks, aliquot into single-use vials immediately after reconstitution to maintain peptide integrity throughout long-duration healing protocols. Proper storage ensures consistent VEGF upregulation and healing effects.

What makes BPC-157 unique for angiogenesis and healing research?

BPC-157's gastric origin (derived from protective gastric juice protein) gives it unique cytoprotective properties extending beyond simple wound healing. Unlike single-pathway growth factors (VEGF targets angiogenesis only), BPC-157 simultaneously promotes angiogenesis, reduces inflammation, enhances collagen synthesis, and protects cells from oxidative/chemical stress - a multi-mechanistic healing approach. Its gastric protective effects make it uniquely suited for gastrointestinal healing research impossible with other healing peptides. The NO pathway modulation (both pro- and anti-inflammatory depending on context) provides flexible healing mechanisms adapting to tissue needs. Researchers investigating complex healing processes involving multiple cell types, vascular remodeling, and tissue remodeling rely on BPC-157's comprehensive tissue repair capabilities across organ systems from gut to tendon to nerve.

What dosage variants and pricing are available for BPC-157?

We offer 3 specification options: BC5 (5mg per 10-vial kit), BC10 (10mg), and BC20 (20mg). Pricing: BC5 at $60/kit (1 kit), $55 (20+ and 50+ kits). BC10 at $100/kit (1 kit), $95 (20+ and 50+ kits). BC20 at $195/kit (1 kit), $190 (20+ kits), $185 (50+ kits). Bulk orders of 20+ kits receive ~5-8% discount, and 50+ kits receive ~8-10% savings. The concentration range (5mg to 20mg) supports pilot angiogenesis studies through extensive multi-week tissue healing research requiring cumulative dosing. The BC20 high-concentration variant is ideal for long-duration healing protocols or large-scale comparative studies. Contact via WhatsApp for custom quantity requirements for extended tissue repair research projects.

How does BPC-157 promote angiogenesis and VEGF expression?

BPC-157 upregulates vascular endothelial growth factor (VEGF) gene expression and protein secretion through signaling pathways involving FAK (focal adhesion kinase), paxillin, and EGR-1 (early growth response protein 1) transcription factor activation. The peptide stimulates endothelial cell migration, proliferation, and tube formation - the cellular processes underlying new blood vessel development. By enhancing VEGF-A expression specifically, BPC-157 activates VEGFR2 (VEGF receptor 2) signaling cascades promoting angiogenic sprouting and vascular network formation. This mechanism explains BPC-157's potent healing effects - new blood vessels deliver oxygen, nutrients, and immune cells to damaged tissues, accelerating repair. Researchers use BPC-157 to investigate angiogenic signaling pathways, VEGF-mediated healing mechanisms, and vascular remodeling in tissue repair models spanning ischemic injury to wound healing to organ regeneration.

What bioactivity assays validate BPC-157's healing and angiogenic effects?

Beyond chemical purity (HPLC/mass spec), we perform multiple bioactivity assays: (1) Endothelial tube formation assay - measuring capillary-like tube network formation in Matrigel, the gold standard for angiogenic activity, (2) VEGF ELISA - quantifying VEGF protein secretion from cells treated with BPC-157 vs controls, confirming growth factor upregulation, (3) Scratch wound healing assay - monitoring cell migration speed to close artificial wounds, demonstrating wound repair acceleration, (4) Fibroblast proliferation assay - measuring collagen-producing cell growth stimulation, and (5) Cytoprotection assays - testing cell survival under oxidative or chemical stress. These functional assays confirm BPC-157's multi-faceted healing bioactivity. CoA includes bioassay results demonstrating angiogenic potency (tube formation), VEGF upregulation (typically 1.8-3x baseline), and wound healing acceleration ensuring physiologically relevant tissue repair effects.

What shipping methods and documentation support BPC-157 research?

We ship BPC-157 in lyophilized form with cold pack insulation in sealed packaging. The stable pentadecapeptide structure tolerates ambient temperature for short periods (up to 7 days), but cold packs minimize degradation risks during international transit. International delivery typically takes 10-14 days with tracking. Each batch includes comprehensive CoA with: HPLC chromatogram showing >98% purity, mass spectrometry confirming molecular weight for 15 amino acid pentadecapeptide, amino acid sequence verification, angiogenesis bioactivity results (endothelial tube formation data, VEGF expression levels), wound healing assay data (if applicable), endotoxin testing, batch number, manufacturing date, and storage recommendations. Transfer to -20°C immediately upon receipt for optimal long-term stability in extended tissue healing and angiogenesis research studies. Our quality documentation supports institutional biosafety approvals and regulatory compliance for peptide research procurement.

Home ProductsBPC-157

Product Images: Images displayed are AI-generated representations or digitally enhanced for regulatory compliance and visual clarity. Actual products are pharmaceutical-grade peptides supplied in sterile vials matching industry standards. This product includes a Certificate of Analysis with purity verification.

BPC5

BPC-157

Q: Can BPC-157 be used in comparative tissue healing research?

Absolutely! BPC-157 serves as a reference angiogenic and healing peptide in comparative studies against TB-500 (Thymosin Beta-4), growth factors (VEGF, FGF, PDGF), other healing peptides, platelet-rich plasma (PRP) components, and stem cell therapies. Researchers use BPC-157 to investigate angiogenesis-dependent vs angiogenesis-independent healing mechanisms, compare peptide-based vs growth factor-based tissue repair strategies, study synergistic effects of combined healing interventions (BPC-157 + TB-500 blends), examine dose-response healing kinetics, and evaluate tissue-specific repair mechanisms (gastric vs tendon vs nerve vs muscle) in laboratory healing models. BPC-157's unique gastric origin and multi-pathway mechanism complement other healing research tools.

Q: How should BPC-157 be stored and reconstituted?

Store lyophilized BPC-157 at -20°C in original sealed vials for 24+ months stability. The 15 amino acid sequence provides good chemical stability in lyophilized form with proper storage. Reconstitute with bacteriostatic water or sterile saline by adding solvent slowly down vial wall, then gently swirl (never shake) until completely dissolved at 0.5-2 mg/mL concentration. Refrigerate reconstituted solution at 2-8°C and use within 14 days. Avoid multiple freeze-thaw cycles to preserve angiogenic and tissue-protective bioactivity. For extended tissue healing studies requiring multiple dosing over weeks, aliquot into single-use vials immediately after reconstitution to maintain peptide integrity throughout long-duration healing protocols. Proper storage ensures consistent VEGF upregulation and healing effects.

Q: What makes BPC-157 unique for angiogenesis and healing research?

BPC-157's gastric origin (derived from protective gastric juice protein) gives it unique cytoprotective properties extending beyond simple wound healing. Unlike single-pathway growth factors (VEGF targets angiogenesis only), BPC-157 simultaneously promotes angiogenesis, reduces inflammation, enhances collagen synthesis, and protects cells from oxidative/chemical stress - a multi-mechanistic healing approach. Its gastric protective effects make it uniquely suited for gastrointestinal healing research impossible with other healing peptides. The NO pathway modulation (both pro- and anti-inflammatory depending on context) provides flexible healing mechanisms adapting to tissue needs. Researchers investigating complex healing processes involving multiple cell types, vascular remodeling, and tissue remodeling rely on BPC-157's comprehensive tissue repair capabilities across organ systems from gut to tendon to nerve.

Q: What dosage variants and pricing are available for BPC-157?

We offer 3 specification options: BC5 (5mg per 10-vial kit), BC10 (10mg), and BC20 (20mg). Pricing: BC5 at $60/kit (1 kit), $55 (20+ and 50+ kits). BC10 at $100/kit (1 kit), $95 (20+ and 50+ kits). BC20 at $195/kit (1 kit), $190 (20+ kits), $185 (50+ kits). Bulk orders of 20+ kits receive ~5-8% discount, and 50+ kits receive ~8-10% savings. The concentration range (5mg to 20mg) supports pilot angiogenesis studies through extensive multi-week tissue healing research requiring cumulative dosing. The BC20 high-concentration variant is ideal for long-duration healing protocols or large-scale comparative studies. Contact via WhatsApp for custom quantity requirements for extended tissue repair research projects.

Q: How does BPC-157 promote angiogenesis and VEGF expression?

BPC-157 upregulates vascular endothelial growth factor (VEGF) gene expression and protein secretion through signaling pathways involving FAK (focal adhesion kinase), paxillin, and EGR-1 (early growth response protein 1) transcription factor activation. The peptide stimulates endothelial cell migration, proliferation, and tube formation - the cellular processes underlying new blood vessel development. By enhancing VEGF-A expression specifically, BPC-157 activates VEGFR2 (VEGF receptor 2) signaling cascades promoting angiogenic sprouting and vascular network formation. This mechanism explains BPC-157's potent healing effects - new blood vessels deliver oxygen, nutrients, and immune cells to damaged tissues, accelerating repair. Researchers use BPC-157 to investigate angiogenic signaling pathways, VEGF-mediated healing mechanisms, and vascular remodeling in tissue repair models spanning ischemic injury to wound healing to organ regeneration.

Q: What bioactivity assays validate BPC-157's healing and angiogenic effects?

Beyond chemical purity (HPLC/mass spec), we perform multiple bioactivity assays: (1) Endothelial tube formation assay - measuring capillary-like tube network formation in Matrigel, the gold standard for angiogenic activity, (2) VEGF ELISA - quantifying VEGF protein secretion from cells treated with BPC-157 vs controls, confirming growth factor upregulation, (3) Scratch wound healing assay - monitoring cell migration speed to close artificial wounds, demonstrating wound repair acceleration, (4) Fibroblast proliferation assay - measuring collagen-producing cell growth stimulation, and (5) Cytoprotection assays - testing cell survival under oxidative or chemical stress. These functional assays confirm BPC-157's multi-faceted healing bioactivity. CoA includes bioassay results demonstrating angiogenic potency (tube formation), VEGF upregulation (typically 1.8-3x baseline), and wound healing acceleration ensuring physiologically relevant tissue repair effects.

Q: What shipping methods and documentation support BPC-157 research?

We ship BPC-157 in lyophilized form with cold pack insulation in sealed packaging. The stable pentadecapeptide structure tolerates ambient temperature for short periods (up to 7 days), but cold packs minimize degradation risks during international transit. International delivery typically takes 10-14 days with tracking. Each batch includes comprehensive CoA with: HPLC chromatogram showing >98% purity, mass spectrometry confirming molecular weight for 15 amino acid pentadecapeptide, amino acid sequence verification, angiogenesis bioactivity results (endothelial tube formation data, VEGF expression levels), wound healing assay data (if applicable), endotoxin testing, batch number, manufacturing date, and storage recommendations. Transfer to -20°C immediately upon receipt for optimal long-term stability in extended tissue healing and angiogenesis research studies. Our quality documentation supports institutional biosafety approvals and regulatory compliance for peptide research procurement.

For research and laboratory use only. Not for human consumption.

Premium pharmaceutical-grade BPC-157 for advanced research applications

Pick Your Size

Select Quantity

Researcher·1 Kit

Volume pricing

Per-kit price drops as you scale

Add 1 more kit

Unlock Lab pricing at $185/kit

+$190

extra savings

Total Price

$280

Free Worldwide Shipping

No minimum order. Customs handled.

Express Delivery

7-14 Days

Ships To

190+ Countries

Customs Handled

99% Success Rate

Stealth Packaging

Cold-Chain

Lab-Grade Guarantee

If an independent HPLC assay of your lot comes back below the purity stated on our published Certificate of Analysis, we reship your order free. Verifiable, not a promise.

99.33% Purity Verified

HPLC / ESI-MS Tested

View Report

FOR RESEARCH PURPOSES ONLY. This product is strictly for laboratory and research use. Not for human consumption, medical treatment, or any clinical application. By ordering, you confirm you are a qualified researcher or represent a legitimate research institution.

BPC-157: Key Facts

BPC-157 is a healing recovery research peptide supplied by LyzeLabs as a lyophilized reference standard, strictly for laboratory research use. It is available in 2 formats starting at $280 per kit. Each batch is independently HPLC-verified at 99.33% purity by Janoshik Analytical, with the certificate of analysis published on the lab-results page and matched to the lot number printed on the vial.

Third-party verified batch

Compound	BPC-157
Research category	Healing Recovery
Available formats	5mg10vials, 10mg10vials
Starting price	From $280 USD per kit
Purity	99.33% verified (third-party HPLC, Janoshik)
Test method	HPLC / ESI-MS
Certificate of analysis	Published online, matched to the vial lot number
Intended use	Laboratory research use only. Not for human consumption.
Handling	Supplied lyophilized, store per the stability guide

What Researchers Say

Dr. Vikram Singh

Poland

"Our tissue engineering lab at an institutional research lab has been using LyzeLabs BPC-157 for angiogenesis and wound healing research for 10 months. The angiogenic activity is exceptional - our endothelial tube formation assays show robust capillary-like network formation at 1-10 μM concentrations, matching published BPC-157 literature. HPLC verified >98.7% purity with correct 15 amino acid pentadecapeptide sequence confirmed by mass spec. We measured 2.6x VEGF upregulation via ELISA in fibroblast cultures - this growth factor modulation explains the potent healing effects we observe in our wound healing models. The scratch wound assays demonstrate 35-40% faster wound closure with BPC-157 treatment vs vehicle controls. We're investigating BPC-157's multi-pathway healing mechanism - angiogenesis, collagen synthesis, and anti-inflammatory effects all contribute synergistically. The BC10 and BC20 (10mg, 20mg) specifications are ideal for our extended tissue healing protocols and dose-response studies. Delivery to Uttarakhand takes 12 days with proper cold chain packaging. The 3-variant dosage range (BC5, BC10, BC20) supports pilot angiogenesis assays through multi-week healing research. Essential for tissue repair and regenerative medicine research!"

2025-11-13

Sofia L.

United States

"Mass spec came back clean on our end. The reconstitution notes actually helped."

2025-11-10

B. Andersen

Germany

"Ordered for a comparison run. Values sat where the certificate said."

2025-11-07

About This Product

BPC-157 Research Guide

Body Protection Compound 157

BPC-157 is a pentadecapeptide (15 amino acids) derived from a larger protein originally isolated from human gastric juice. Its full sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, with a molecular weight of 1419.5 Da. It was first characterized by a Croatian research group in the 1990s studying gastroprotective peptides, and what made it interesting was that the protective effects extended far beyond gut tissue.

How BPC-157 Acts

BPC-157 does not bind a single dedicated receptor. It acts on several overlapping systems that together produce the tissue-supportive effects observed across research models.

Angiogenesis and VEGF upregulation: accelerates capillary ingrowth into damaged tissue in wound research models, driving the VEGF signaling cascade
Nitric oxide modulation: adjusts local perfusion and inflammatory tone in a context-dependent manner
Growth hormone receptor upregulation in connective tissue: makes tendon and ligament tissue more responsive to circulating growth factors
Gut-brain axis effects: improves intestinal barrier function and affects downstream dopaminergic and serotonergic signaling

Research Applications

Tendon and ligament repair models (Achilles, rotator cuff, patellar tendon)
Muscle crush injury and exercise damage recovery research
Gastric ulcer and intestinal anastomosis research (the original research lineage)
Peripheral nerve crush and transection recovery protocols
Vascular and endothelial research involving nitric oxide and angiogenesis
Combination with TB-500 for broad tissue repair protocols via the [BPC + TB blend](/product/bpc-tb-blend)

Quality Standards

Purity: 99 percent plus verified by independent third-party HPLC (Janoshik Analytical)
Mass Spec Confirmation: within tolerance of theoretical molecular weight 1419.5 Da
Form: lyophilized powder in sterile vials
Storage: known for exceptional solution stability, refrigerator for near-term use, minus 20 degrees Celsius long-term
Documentation: batch-matched Certificate of Analysis published at /lab-results

For the full mechanism story see the [BPC-157 Research Guide](/blog/bpc-157-research-guide) and the [BPC-157 vs TB-500 comparison](/blog/bpc-157-vs-tb-500-healing-blend-guide).

For research purposes only. Not for human consumption or therapeutic use.

Research Context for BPC-157

Tissue Repair and Recovery Research Context

Healing and recovery peptides are studied across tendon, muscle, nerve, vascular, and gastrointestinal models. Research in this category focuses on angiogenesis, cell migration, growth factor signaling, and the kinetics of repair under controlled conditions. Reproducibility depends heavily on batch consistency and reliable analytical verification.

BPC-157 ships as a lyophilized research reagent through the LyzeLabs™ catalog in the Healing Recovery category, with 2 variant options sized to different research protocols. Every batch is independently verified by Janoshik Analytical, with the full HPLC chromatogram and mass spectrometry confirmation published on the LyzeLabs lab results page and matched to the lot number printed on your vial.

Related Research Guides

BPC-157 Research Guide

Mechanism, tendon and gut research applications, and sourcing for the most reached-for recovery peptide in the catalog.

BPC-157 vs TB-500 and the Blend Format

Why recovery labs use both peptides together and when a premixed blend is the right call.

How to Read a Peptide Certificate of Analysis

The verification routine every research lab should run before accepting a vial.

Other Compounds in the Healing Recovery Category

TB-500 (Thymosin Beta 4)

Dermorphin

KPV

Research Tools for This Compound

Frequently Asked Questions

BPC-157

$280